Post-viral atopic airway disease: pathogenesis and potential avenues for intervention

References

• Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–545.
   PubMed Web of Science ®Google Scholar
• Martinez FD. Viruses and atopic sensitization in the first years of life. Am J Respir Crit Care Med. 2000;162(3 Pt 2):S95–S99.
   PubMed Web of Science ®Google Scholar
• Peebles RS Jr. Viral infections, atopy, and asthma: is there a causal relationship? J Allergy Clin Immunol. 2004;113(1Suppl):S15–S18.
   PubMedGoogle Scholar
• Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–672.
   PubMed Web of Science ®Google Scholar
• Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045–1052.
   PubMed Web of Science ®Google Scholar
• Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501–1507.
   PubMed Web of Science ®Google Scholar
• Gern JE, Palmenberg AC. Fields virology. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Lukkarinen M, Koistinen A, Turunen R, et al. Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age. J Allergy Clin Immunol. 2017;140(4):988–995.
   PubMed Web of Science ®Google Scholar
• Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017;139(2):501–507.
   PubMed Web of Science ®Google Scholar
• Afonso CL, Amarasinghe GK, Banyai K, et al. Taxonomy of the order mononegavirales: update 2016. Arch Virol. 2016;161(8):2351–2360.
   PubMed Web of Science ®Google Scholar
• Collins PL, Karron RA. Fields virology. Philadelphia (PA): Wolters Kluwer/Lippincott Williams & Wilkins Health; 2013.
   Google Scholar
• Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008;82(5):2040–2055.
   PubMed Web of Science ®Google Scholar
• Psarras S, Papadopoulos NG, Johnston SL. Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev. 2004;5(Suppl A):S179–184.
   PubMedGoogle Scholar
• Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–958.
   PubMed Web of Science ®Google Scholar
• Lu S, Hartert TV, Everard ML, et al. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood. Pediatr Pulmonol. 2016;51(12):1382–1392.
   PubMed Web of Science ®Google Scholar
• Thomsen SF, van der Sluis S, Stensballe LG, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med. 2009;179(12):1091–1097.
   PubMed Web of Science ®Google Scholar
• Frick OL, German DF, Mills J. Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol. 1979;63(4):228–241.
   PubMed Web of Science ®Google Scholar
• Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95(4):500–505.
   PubMed Web of Science ®Google Scholar
• Carroll KN, Wu P, Gebretsadik T, et al. Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. J Allergy Clin Immunol. 2009;123(4):964–966.
   PubMed Web of Science ®Google Scholar
• Grayson MH, Cheung D, Rohlfing MM, et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med. 2007;204(11):2759–2769.
   PubMed Web of Science ®Google Scholar
• Walter MJ, Morton JD, Kajiwara N, et al. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest. 2002;110(2):165–175.
   PubMed Web of Science ®Google Scholar
• Martorano LM, Grayson MH. Respiratory viral infections and atopic development: from possible mechanisms to advances in treatment. Eur J Immunol. 2018;48(3):407–414.
   PubMed Web of Science ®Google Scholar
• Cheung DS, Ehlenbach SJ, Kitchens RT, et al. Cutting edge: CD49d+ neutrophils induce FcepsilonRI expression on lung dendritic cells in a mouse model of postviral asthma. J Immunol. 2010;185(9):4983–4987.
   PubMed Web of Science ®Google Scholar
• Cheung DS, Sigua JA, Simpson PM, et al. Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease. J Allergy Clin Immunol. 2018;142(4):1206–1217.
   PubMed Web of Science ®Google Scholar
• Cheung DS, Ehlenbach SJ, Kitchens T, et al. Development of atopy by severe paramyxoviral infection in a mouse model. Ann Allergy Asthma Immunol. 2010;105(6):437–443 e431.
   PubMed Web of Science ®Google Scholar
• Khan SH, Grayson MH. Cross-linking IgE augments human conventional dendritic cell production of CC chemokine ligand 28. J Allergy Clin Immunol. 2010;125(1):265–267.
   PubMed Web of Science ®Google Scholar
• Vasudev M, Cheung DS, Pincsak H, et al. Expression of high-affinity IgE receptor on human peripheral blood dendritic cells in children. PLoS One. 2012;7(2):e32556.
   PubMed Web of Science ®Google Scholar
• Subrata LS, Bizzintino J, Mamessier E, et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol. 2009;183(4):2793–2800.
   PubMed Web of Science ®Google Scholar
• Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012;130(2):489–495.
   PubMed Web of Science ®Google Scholar
• Drake MG, Bivins-Smith ER, Proskocil BJ, et al. Human and mouse eosinophils have antiviral activity against parainfluenza virus. Am J Respir Cell Mol Biol. 2016;55(3):387–394.
   PubMed Web of Science ®Google Scholar
• Ramirez GA, Yacoub MR, Ripa M, et al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018;2018:9095275.
   PubMed Web of Science ®Google Scholar
• Samarasinghe AE, Melo RC, Duan S, et al. Eosinophils promote antiviral immunity in mice infected with influenza a virus. J Immunol. 2017;198(8):3214–3226.
   PubMed Web of Science ®Google Scholar
• Mejias A, Dimo B, Suarez NM, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 2013;10(11):e1001549.
   PubMed Web of Science ®Google Scholar
• Chaussabel D, Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat Rev Immunol. 2014;14(4):271–280.
   PubMed Web of Science ®Google Scholar
• Trento A, Galiano M, Videla C, et al. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol. 2003;84(Pt 11):3115–3120.
   PubMed Web of Science ®Google Scholar
• Eshaghi A, Duvvuri VR, Lai R, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 2012;7(3):e32807.
   PubMed Web of Science ®Google Scholar
• Esposito S, Piralla A, Zampiero A, et al. Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in five consecutive winter seasons. PLoS One. 2015;10(6):e0129369.
   PubMed Web of Science ®Google Scholar
• Gaymard A, Bouscambert-Duchamp M, Pichon M, et al. Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol. 2018;102:12–18.
   PubMed Web of Science ®Google Scholar
• Pretorius MA, van Niekerk S, Tempia S, et al. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013;208(Suppl 3):S227–237.
   PubMedGoogle Scholar
• Trento A, Casas I, Calderon A, et al. Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol. 2010;84(15):7500–7512.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Fernandez R, Tapia LI, Yang CF, et al. Respiratory syncytial virus genotypes, host immune profiles, and disease severity in young children hospitalized with bronchiolitis. J Infect Dis. 2017;217(1):24–34.
   PubMed Web of Science ®Google Scholar
• Russell CD, Unger SA, Walton M, et al. The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev. 2017;30(2):481–502.
   PubMed Web of Science ®Google Scholar
• Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J. 1999;18(2):115–122.
   PubMed Web of Science ®Google Scholar
• Dimova-Yaneva D, Russell D, Main M, et al. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy. 2004;34(4):555–558.
   PubMed Web of Science ®Google Scholar
• Sigua JA, Buelow B, Cheung DS, et al. CD49d-expressing neutrophils differentiate atopic from nonatopic individuals. J Allergy Clin Immunol. 2014;133(3):901–904 e905.
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983;220(4597):568–575.
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med. 2008;178(8):854–860.
   PubMed Web of Science ®Google Scholar
• Lam BK, Austen KF. Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. Prostaglandins Other Lipid Mediat. 2002;68–69:511–520.
   PubMed Web of Science ®Google Scholar
• Sampson AP, Siddiqui S, Buchanan D, et al. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax. 2000;55(Suppl 2):S28–S31.
   PubMedGoogle Scholar
• Zhang Y, Huang H, Huang J, et al. The −444A/C polymorphism in the LTC4S gene and the risk of asthma: a meta-analysis. Arch Med Res. 2012;43(6):444–450.
   PubMed Web of Science ®Google Scholar
• McGeachie MJ, Davis JS, Kho AT, et al. Asthma remission: predicting future airways responsiveness using an miRNA network. J Allergy Clin Immunol. 2017;140(2):598–600 e598.
   PubMed Web of Science ®Google Scholar
• Foster PS, Plank M, Collison A, et al. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev. 2013;253(1):198–215.
   PubMed Web of Science ®Google Scholar
• Perry MM, Adcock IM, Chung KF. Role of microRNAs in allergic asthma: present and future. Curr Opin Allergy Clin Immunol. 2015;15(2):156–162.
   PubMed Web of Science ®Google Scholar
• McCaskill JL, Ressel S, Alber A, et al. Broad-spectrum inhibition of respiratory virus infection by microRNA mimics targeting p38 MAPK signaling. Mol Ther Nucleic Acids. 2017;7:256–266.
   PubMedGoogle Scholar
• Gutierrez MJ, Gomez JL, Perez GF, et al. Airway secretory microRNAome changes during rhinovirus infection in early childhood. PLoS One. 2016;11(9):e0162244.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Perez-Losada M, Hoptay CE, et al. RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFkappaB signaling. Pediatr Res. 2018;83(3):606–614.
   PubMed Web of Science ®Google Scholar
• Ungvari I, Hullam G, Antal P, et al. Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance. PLoS One. 2012;7(3):e33573.
   PubMed Web of Science ®Google Scholar
• Fodor LE, Gezsi A, Ungvari L, et al. Investigation of the possible role of the Hippo/YAP1 pathway in asthma and allergy. Allergy Asthma Immunol Res. 2017;9(3):247–256.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Jeong IC. Machine learning approaches to personalize early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;1387(1):153–165.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M. Pharmacogenetics and pharmacogenomics. Br J Clin Pharmacol. 2001;52(4):345–347.
   PubMed Web of Science ®Google Scholar
• Thomsen SF, van der Sluis S, Kyvik KO, et al. Estimates of asthma heritability in a large twin sample. Clin Exp Allergy. 2010;40(7):1054–1061.
   PubMed Web of Science ®Google Scholar
• Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull. 2000;56(4):1054–1070.
   PubMed Web of Science ®Google Scholar
• Thompson MD, Capra V, Clunes MT, et al. Cysteinyl leukotrienes pathway genes, atopic asthma and drug response: from population isolates to large genome-wide association studies. Front Pharmacol. 2016;7:299.
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A. 2004;101(52):18099–18104.
   PubMed Web of Science ®Google Scholar
• Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005–1015.
   PubMed Web of Science ®Google Scholar
• Scherzer R, Grayson MH. Heterogeneity and the origins of asthma. Ann Allergy Asthma Immunol. 2018; 121(4): 400–405.
   Google Scholar
• Stokes JR, Casale TB. Characterization of asthma endotypes: implications for therapy. Ann Allergy Asthma Immunol. 2016;117(2):121–125.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10(12):838–848.
   PubMed Web of Science ®Google Scholar
• Ntontsi P, Papathanassiou E, Loukides S, et al. Targeted anti-IL-13 therapies in asthma: current data and future perspectives. Expert Opin Investig Drugs. 2018;27(2):179–186.
   PubMed Web of Science ®Google Scholar
• Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088–1098.
   PubMed Web of Science ®Google Scholar
• Piper E, Brightling C, Niven R, et al. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J. 2013;41(2):330–338.
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388–395.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Akashi K, Watanabe M, et al. Up-regulation of serum periostin and squamous cell carcinoma antigen levels in infants with acute bronchitis due to respiratory syncytial virus. Allergol Int. 2018;67(2):259–265.
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia ML, Calvo C, Moreira A, et al. Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis. Medicine (Baltimore). 2017;96(18):e6787.
   PubMed Web of Science ®Google Scholar
• Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045–1054.
   PubMed Web of Science ®Google Scholar
• Stier MT, Bloodworth MH, Toki S, et al. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol. 2016;138(3):814–824 e811.
   PubMed Web of Science ®Google Scholar
• Saravia J, You D, Shrestha B, et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog. 2015;11(10):e1005217.
   PubMed Web of Science ®Google Scholar
• Forton JT, Rowlands K, Rockett K, et al. Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax. 2009;64(4):345–352.
   PubMed Web of Science ®Google Scholar
• Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791–1799.
   PubMed Web of Science ®Google Scholar
• Zhu Q, McLellan JS, Kallewaard NL, et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017;9:388.
   Web of Science ®Google Scholar
• Mazur NI, Higgins D, Nunes MC, et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018; 18(10): e295–e311.
   PubMed Web of Science ®Google Scholar
• DeVincenzo J, Lambkin-Williams R, Wilkinson T, et al. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2010;107(19):8800–8805.
   PubMed Web of Science ®Google Scholar
• Simoes EAF, Bont L, Manzoni P, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infect Dis Ther. 2018;7(1):87–120.
   PubMed Web of Science ®Google Scholar